Increased Response to Glutamate in Small Diameter Dorsal Root Ganglion Neurons After Sciatic Nerve Injury
Overview
Affiliations
Glutamate in the peripheral nervous system is involved in neuropathic pain, yet we know little how nerve injury alters responses to this neurotransmitter in primary sensory neurons. We recorded neuronal responses from the ex-vivo preparations of the dorsal root ganglia (DRG) one week following a chronic constriction injury (CCI) of the sciatic nerve in adult rats. We found that small diameter DRG neurons (<30 µm) exhibited increased excitability that was associated with decreased membrane threshold and rheobase, whereas responses in large diameter neurons (>30 µm) were unaffected. Puff application of either glutamate, or the selective ionotropic glutamate receptor agonists alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainic acid (KA), or the group I metabotropic receptor (mGluR) agonist (S)-3,5-dihydroxyphenylglycine (DHPG), induced larger inward currents in CCI DRGs compared to those from uninjured rats. N-methyl-D-aspartate (NMDA)-induced currents were unchanged. In addition to larger inward currents following CCI, a greater number of neurons responded to glutamate, AMPA, NMDA, and DHPG, but not to KA. Western blot analysis of the DRGs revealed that CCI resulted in a 35% increase in GluA1 and a 60% decrease in GluA2, the AMPA receptor subunits, compared to uninjured controls. mGluR1 receptor expression increased by 60% in the membrane fraction, whereas mGluR5 receptor subunit expression remained unchanged after CCI. These results show that following nerve injury, small diameter DRG neurons, many of which are nociceptive, have increased excitability and an increased response to glutamate that is associated with changes in receptor expression at the neuronal membrane. Our findings provide further evidence that glutamatergic transmission in the periphery plays a role in nociception.
Solid-State Nanopores for Spatially Resolved Chemical Neuromodulation.
Vacca F, Galluzzi F, Blanco-Formoso M, Gianiorio T, De Fazio A, Tantussi F Nano Lett. 2024; 24(48):15215-15225.
PMID: 39561980 PMC: 11622382. DOI: 10.1021/acs.nanolett.4c02604.
Jang K, Garraway S Neurobiol Pain. 2024; 15:100151.
PMID: 38314104 PMC: 10837099. DOI: 10.1016/j.ynpai.2024.100151.
Zhang Y, Jeske N Mol Pain. 2023; 19:17448069231222406.
PMID: 38073552 PMC: 10722943. DOI: 10.1177/17448069231222406.
Huang L, Sharma D, Feng X, Pan Z, Wu S, Munoz D Br J Pharmacol. 2023; 181(5):735-751.
PMID: 37782223 PMC: 10873045. DOI: 10.1111/bph.16259.
A sensory neuron-specific long non-coding RNA reduces neuropathic pain by rescuing KCNN1 expression.
Wang B, Ma L, Guo X, Du S, Feng X, Liang Y Brain. 2023; 146(9):3866-3884.
PMID: 37012681 PMC: 10473565. DOI: 10.1093/brain/awad110.